You are here

Algernon Pharmaceuticals Inc.

Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
AGN
CSE Index: 
Currency: 

Algernon Pharmaceuticals is a drug re-purposing company that investigates safe, already approved drugs for new disease applications, moving them efficiently and safely into new human trials, developing new formulations and seeking new regulatory approvals in global markets. Algernon specifically investigates compounds that have never been approved in the U.S. or Europe to avoid off label prescription writing.

You are here

Algernon Pharmaceuticals Inc. (AGN)

SEDAR Information

Company Info

Address
Suite 915 - 700 West Pender Street
Vancouver, BC V6C 1G8
Canada
Phone
604-398-4175
Ext
701
Email
chris@algernonpharmaceuticals.com
Website
http://www.algernonpharmaceuticals.com
Listing date
Monday, February 1, 2016
Transfer Agent
AST Trust Company (Canada)
Auditor
Smythe LLP

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
155,089,641
Reserved for Issuance: 
43,366,329

Bulletins

19/01/2021

2021-0122 - Expiry – Algernon Pharmaceuticals Inc. – Warrants (AGN.WT)

le 19 janvier/January 2021

Further to Bulletin 2020-1240, Algernon Pharmaceuticals Inc. warrants will expire on January 21, 2021.

Settlement Terms:  All trades January 19th and 20th  will settle for cash next day. Trades on January 21 will be for cash same day.

The warrants will be halted at noon and delisted at market close January 21, 2021.

Advertisement

Publicité

Latest CSE News

Upcoming Events

PDAC_website.png

Virtual PDAC 2021

Monday, March 8, 2021 to Thursday, March 11, 2021
PDAC_Invite_2021_CSE_Website_740x374_1.jpg

Ridi, Bevi, e Divertiti

Tuesday, March 9, 2021 -
3:00pm to 5:00pm